These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 1679657)

  • 1. Does treatment with beta-adrenoceptor antagonists in vivo alter human adenylate cyclase responsiveness in vitro?
    Michel MC; Klüppel M; Philipp T; Brodde OE
    Br J Clin Pharmacol; 1991 Jul; 32(1):105-9. PubMed ID: 1679657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The local anaesthetic benzyl alcohol attenuates the alpha 2-adrenoceptor-mediated inhibition of human platelet adenylate cyclase activity when stimulated by prostaglandin E1, but not that stimulated by forskolin.
    Spence S; Houslay MD
    Biochem J; 1989 Dec; 264(2):483-8. PubMed ID: 2557841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Forskolin sensitizes human platelet adenylate cyclase to modulation of substrate (MgATP) affinity by hormones.
    Watanabe Y; Jakobs KH
    Biochem J; 1986 Jul; 237(1):273-6. PubMed ID: 3492195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of GTP in prostaglandin E1 stimulation of adenylate cyclase in platelet membranes.
    Stein JM; Martin BR
    Biochem J; 1983 Jul; 214(1):231-4. PubMed ID: 6684425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the beta-adrenergic receptor on the human platelet: a beta 2-subtype.
    Klysner R; Andersen PH; Geisler A; Winther K
    Acta Pharmacol Toxicol (Copenh); 1984 Apr; 54(4):265-9. PubMed ID: 6145292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered G-protein expression and adenylate cyclase activity in platelets of non-insulin-dependent diabetic (NIDDM) male subjects.
    Livingstone C; McLellan AR; McGregor MA; Wilson A; Connell JM; Small M; Milligan G; Paterson KR; Houslay MD
    Biochim Biophys Acta; 1991 Feb; 1096(2):127-33. PubMed ID: 1900442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphocyte adenylate cyclase activity in immunosuppressed patients.
    Michel MC; Brodde OE
    Eur J Clin Pharmacol; 1989; 37(1):41-3. PubMed ID: 2591461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of adenylate cyclase in human retinal pigment epithelial cells in vitro.
    Friedman Z; Hackett SF; Campochiaro PA
    Exp Eye Res; 1987 Apr; 44(4):471-9. PubMed ID: 2885210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Forskolin-stimulated adenylyl cyclase activity is decreased but beta 2-adrenoceptor function is unchanged in primary hypertension.
    Blankesteijn WM; Willems PH; Graafsma SJ; de Pont JJ; Thien T
    J Cardiovasc Pharmacol; 1993 Nov; 22(5):695-701. PubMed ID: 7506320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of beta blocking agents on the density of beta adrenoceptors and adenylate cyclase response in human myocardium: intrinsic sympathomimetic activity favours receptor upregulation.
    Golf S; Hansson V
    Cardiovasc Res; 1986 Sep; 20(9):637-44. PubMed ID: 2878724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein kinase C interferes with Ni-mediated inhibition of human platelet adenylate cyclase.
    Watanabe Y; Horn F; Bauer S; Jakobs KH
    FEBS Lett; 1985 Nov; 192(1):23-7. PubMed ID: 4054315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection and analysis of agonist-induced formation of the complex of the stimulatory guanine nucleotide-binding protein with adenylate cyclase in intact wild-type and beta 2-adrenoceptor-expressing NG108-15 cells.
    Kim GD; Carr IC; Milligan G
    Biochem J; 1995 May; 308 ( Pt 1)(Pt 1):275-81. PubMed ID: 7538756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of adenylate cyclase activity during the reversible shape change in human platelets.
    Dimitrov DP; Bühler FR
    Biochem Biophys Res Commun; 1988 Apr; 152(2):649-57. PubMed ID: 3365246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of beta 2-glycoprotein I on the activity of adenylate cyclase in platelet membranes.
    Schousboe I
    Thromb Res; 1983 Nov; 32(3):291-9. PubMed ID: 6686348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different effects of various beta-adrenoceptor antagonists on adenylate cyclase, guanylate cyclase and calmodulin-dependent phosphodiesterase in heart.
    Kudo S; Nozawa Y
    Biochem Pharmacol; 1985 May; 34(10):1659-64. PubMed ID: 2860906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hydroxybenzylpindolol--activation mechanism of adenylate cyclase and beta-adrenergic receptor].
    Yamamura H
    Nihon Rinsho; 1976; 34(3):534-9. PubMed ID: 6811
    [No Abstract]   [Full Text] [Related]  

  • 17. Differential effects of fluoride on adenylate cyclase activity and guanine nucleotide regulation of agonist high-affinity receptor binding.
    Stadel JM; Crooke ST
    Biochem J; 1988 Aug; 254(1):15-20. PubMed ID: 2845943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alterations in cardiac membrane beta-adrenoceptors and adenylyl cyclase due to hypochlorous acid.
    Persad S; Elimban V; Siddiqui F; Dhalla NS
    J Mol Cell Cardiol; 1999 Jan; 31(1):101-11. PubMed ID: 10072719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of alpha 2-adrenoceptor agonists and of related compounds on aggregation of, and on adenylate cyclase activity in, human platelets.
    Clare KA; Scrutton MC; Thompson NT
    Br J Pharmacol; 1984 Jun; 82(2):467-76. PubMed ID: 6145472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relative potencies of various beta-adrenoceptor antagonists (BAA) at the level of the human myocardial beta-adrenoceptor-adenylate cyclase (AC) complex. Is intrinsic sympathomimetic activity (ISA) due to AC activation?
    Golf S; Hansson V
    Scand J Clin Lab Invest; 1986 Apr; 46(2):121-30. PubMed ID: 2872714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.